NewAmsterdam Pharma Company N.V. (NAMS)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMS · CIK 1936258

4 · Jan 7, 2026 · Kastelein Johannes Jacob Pieter sold 6,000 shares at $33.25/share ($199.5K); was granted 25.50K shares

Kastelein Johannes Jacob Pieter sold 6,000 shares at $33.25/share ($199.5K); was granted 25.50K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).